Asia Pacific Chemotherapy market

Japan accounted for the largest market share in 2017 in the asia pacific chemotherapy market, and is expected to reach usd 4158.06 million in 2024 from usd 1943.78 million in 2017. however, india is the fastest growing market, which is expected to grow at a cagr of 12.54% during the forecast period 2018 - 2024. alkylating agents segment accounted for the largest market share in 2017, this market is expected to reach usd 4951.07 million in 2024 from usd 2203.46 million in 2017. this market is projected to grow at a cagr of 12.35% during the forecast period from 2018 - 2024. however, alkylating agents segment is the fastest growing market, which is expected to grow at a cagr of 12.35% during the forecast period 2018 - 2024. intravenous segment accounted for the largest market share in 2017, this market is expected to reach usd 6191.57 million in 2024 from usd 2864.89 million in 2017. this market is projected to grow at a cagr of 11.64% during the forecast period from 2018 - 2024. however, oral segment is the fastest growing market, which is expected to grow at a cagr of 12.54% during the forecast period 2018 - 2024. indication others segment accounted for the largest market share in 2017, this market is expected to reach usd 5021.62 million in 2024 from usd 2336.80 million in 2017. this market is projected to grow at a cagr of 11.55% during the forecast period from 2018 - 2024. however, breast cancer segment is the fastest growing market, which is expected to grow at a cagr of 12.54% during the forecast period 2018 - 2024. speciality centers segment accounted for the largest market share in 2017, this market is expected to reach usd 7969.54 million in 2024 from usd 3522.27 million in 2017. this market is projected to grow at a cagr of 12.37% during the forecast period from 2018 - 2024. however, speciality centers segment is the fastest growing market, which is expected to grow at a cagr of 12.37% during the forecast period 2018 - 2024.